ArticleBone marrow transplantation2016

Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab.

B Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.